On the public citation graph
First generation aromatase inhibitors ? aminoglutethimide and testololactone
0 signed · 159 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.1960.03030160052013openalex-snapshot
NEW DRUGS AND DEVELOPMENTS IN THERAPEUTICS
inferredcites →https://doi.org/10.1001/jama.223.11.1267openalex-snapshot
Androgenic therapy for advanced breast cancer in women. A report of the cooperative breast cancer group
inferredcites →https://doi.org/10.1002/1097-0142(196205/06)15:3<633::aid-cncr2820150327>3.0.co;2-lopenalex-snapshot
Hormonal therapy in cancer of the breast.XIX. Effect of oral administration of Δ1-testololactone on clinical course and hormonal excretion
inferredcites →https://doi.org/10.1002/1097-0142(1967)20:3<458::aid-cncr2820200314>3.0.co;2-uopenalex-snapshot
High-dosage Δ1-testololactone therapy of disseminated carcinoma of the breast
inferredcites →https://doi.org/10.1002/1097-0142(196901)23:1<109::aid-cncr2820230112>3.0.co;2-1openalex-snapshot
Clinical trial of Δ1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer:A report of the cooperative breast cancer group
inferredcites →https://doi.org/10.1002/1097-0142(197307)32:1<31::aid-cncr2820320104>3.0.co;2-5openalex-snapshot
Preliminary trial of aminoglutethimide in breast cancer
inferredcites →https://doi.org/10.1002/1097-0142(197401)33:1<9::aid-cncr2820330104>3.0.co;2-#openalex-snapshot
A dose response evaluation of delta‐1‐testololactone in advanced breast cancer
inferredcites →https://doi.org/10.1002/1097-0142(197402)33:2<503::aid-cncr2820330227>3.0.co;2-lopenalex-snapshot
Medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer
inferredcites →https://doi.org/10.1002/1097-0142(197702)39:2<542::aid-cncr2820390224>3.0.co;2-ropenalex-snapshot
Medical and surgical adrenalectomy in patients with advanced breast carcinoma
inferredcites →https://doi.org/10.1002/1097-0142(197706)39:6<2948::aid-cncr2820390681>3.0.co;2-9openalex-snapshot
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer
inferredcites →https://doi.org/10.1002/1097-0142(197906)43:6<2207::aid-cncr2820430608>3.0.co;2-1openalex-snapshot
A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancer
inferredcites →https://doi.org/10.1002/1097-0142(19810515)47:10<2398::aid-cncr2820471013>3.0.co;2-oopenalex-snapshot
Advanced breast cancer—Additive hormonal therapy
inferredcites →https://doi.org/10.1002/1097-0142(19820315)49:6<1145::aid-cncr2820490614>3.0.co;2-7openalex-snapshot
Medical adrenalectomy in patients with advanced breast cancer
inferredcites →https://doi.org/10.1002/1097-0142(19821101)50:9<1708::aid-cncr2820500909>3.0.co;2-8openalex-snapshot
Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifen
inferredcites →https://doi.org/10.1002/1097-0142(19821201)50:11<2265::aid-cncr2820501106>3.0.co;2-#openalex-snapshot
A randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer
inferredcites →https://doi.org/10.1002/1097-0142(19830215)51:4<581::aid-cncr2820510404>3.0.co;2-gopenalex-snapshot
Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer: A prospective randomized study
inferredcites →https://doi.org/10.1002/1097-0142(19861101)58:9<1985::aid-cncr2820580905>3.0.co;2-8openalex-snapshot
Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer: A phase II study of the association of medical oncology of the German cancer society (AIO)
inferredcites →https://doi.org/10.1002/1097-0142(19870215)59:4<779::aid-cncr2820590419>3.0.co;2-uopenalex-snapshot
Aromatase activity in primary and metastatic human breast cancer
inferredcites →https://doi.org/10.1002/1097-0142(19871101)60:9<2137::aid-cncr2820600902>3.0.co;2-ropenalex-snapshot
Combination hormone therapy for metastatic breast cancer: An ECOG study of megestrol and aminoglutethimide
inferredcites →https://doi.org/10.1002/1097-0142(19900501)63:9<1673::aid-cncr2820630904>3.0.co;2-copenalex-snapshot
Aminoglutethimide in patients with metastatic breast cancer
inferredcites →https://doi.org/10.1007/bf00258132openalex-snapshot
A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer
inferredcites →https://doi.org/10.1007/bf01805860openalex-snapshot
Medical adrenalectomy in patients with advanced breast cancer resistant to anti-oestrogen treatment
inferredcites →https://doi.org/10.1007/bf01806236openalex-snapshot
Aminoglutethimide treatment in advanced breast cancer: An efficient therapy as a late endocrine alternative in a sequential therapeutic approach
inferredcites →https://doi.org/10.1007/bf01806244openalex-snapshot
Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma
inferredcites →https://doi.org/10.1007/bf01810736openalex-snapshot
Megestrol acetate versus aminoglutethimide for metastatic breast cancer
inferredcites →https://doi.org/10.1007/bf01886732openalex-snapshot
Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy
inferredcites →https://doi.org/10.1007/bf01961246openalex-snapshot
Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen
inferredcites →https://doi.org/10.1007/bf02580046openalex-snapshot
Aminoglutethimide (AG) in advanced breast cancer (BC)-low dose VS standard dose
inferredcites →https://doi.org/10.1016/0022-4731(75)90149-1openalex-snapshot
Studies of human placental aromatase
inferredcites →https://doi.org/10.1016/0022-4804(83)90086-0openalex-snapshot
Aminoglutethimide stimulates extra adrenal δ-4-androstenedione production
inferredcites →https://doi.org/10.1016/0039-128x(81)90087-8openalex-snapshot
Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo
inferredcites →https://doi.org/10.1016/0140-6736(92)90997-hopenalex-snapshot
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
inferredcites →https://doi.org/10.1016/0277-5379(83)90390-5openalex-snapshot
Aminoglutethimide for the treatment of advanced postmenopausal breast cancer
inferredcites →https://doi.org/10.1016/0277-5379(84)90230-xopenalex-snapshot
Hydrocortisone alone vs hydrocortisone plus aminogluthethimide: a comparison of the endocrine effects in postmenopausal breast cancer
inferredcites →https://doi.org/10.1016/0277-5379(85)90007-0openalex-snapshot
Aminoglutethimide in advanced breast cancer: Clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day
inferredcites →https://doi.org/10.1016/0277-5379(85)90128-2openalex-snapshot
Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized study of CMF vs CMF plus tamoxifen
inferredcites →https://doi.org/10.1016/0277-5379(85)90195-6openalex-snapshot
Low-dose aminoglutethimide without steroid replacement in the treatment of postmenopausal women with advanced breast cancer
inferredcites →https://doi.org/10.1016/0277-5379(86)90147-1openalex-snapshot
Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer
inferredcites →https://doi.org/10.1016/0277-5379(89)90032-1openalex-snapshot
Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer
inferredcites →https://doi.org/10.1016/0277-5379(89)90396-9openalex-snapshot
Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancer
inferredcites →https://doi.org/10.1016/0277-5379(90)90162-mopenalex-snapshot
Combination of tamoxifen, aminoglutethimide, danazol and medroxyprogesterone acetate in advanced breast cancer
inferredcites →https://doi.org/10.1016/0305-7372(84)90033-1openalex-snapshot
Aminoglutethimide as an aromatase inhibitor in the treatment of cancer
inferredcites →https://doi.org/10.1016/0305-7372(89)90012-1openalex-snapshot
Aromatase inhibitors in the treatment of advanced breast cancer
inferredcites →https://doi.org/10.1016/s0021-9258(20)79735-8openalex-snapshot
Utilization of Oxygen and Reduced Nicotinamide Adenine Dinucleotide Phosphate by Human Placental Microsomes during Aromatization of Androstenedione
inferredcites →https://doi.org/10.1016/s0021-9258(20)79736-xopenalex-snapshot
The Involvement of Human Placental Microsomal Cytochrome P-450 in Aromatization
inferredcites →https://doi.org/10.1016/s0140-6736(84)90596-8openalex-snapshot
LOW-DOSE AMINOGLUTETHIMIDE IN TREATMENT OF ADVANCED BREAST CANCER
inferredcites →https://doi.org/10.1016/s0140-6736(84)91872-5openalex-snapshot
TREATMENT OF DISSEMINATED BREAST CANCER WITH TAMOXIFEN, AMINOGLUTETHIMIDE, HYDROCORTISONE, AND DANAZOL, USED IN COMBINATION OR SEQUENTIALLY
inferredcites →https://doi.org/10.1016/s0140-6736(84)92732-6openalex-snapshot
AMINOGLUTETHIMIDE AND SERUM CHOLESTEROL
inferredcites →https://doi.org/10.1016/s0140-6736(85)91955-5openalex-snapshot
LOW-DOSE AMINOGLUTETHIMIDE AND AROMATASE INHIBITION
inferredcites →https://doi.org/10.1016/s0167-8140(87)80233-5openalex-snapshot
A randomized phase II trial of aminoglutethimide and hydrocortisone versus combined aminoglutethimide, hydrocortisone and fluoxymesterone in advanced breast cancer
inferredcites →https://doi.org/10.1021/ja01118a530openalex-snapshot
OXIDATION OF STEROIDS BY MICRO ÖRGANISMS. III. SIDE CHAIN DEGRADATION, RING D-CLEAVAGE AND DEHYDROGENATION IN RING A
inferredcites →https://doi.org/10.1038/bjc.1985.223openalex-snapshot
A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients
inferredcites →https://doi.org/10.1038/bjc.1989.231openalex-snapshot
Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide
inferredcites →https://doi.org/10.1042/bj1300019pbopenalex-snapshot
Inhibition studies on the aromatization of androst-4-ene-3,17-dione by human placental microsomal preparations
inferredcites →https://doi.org/10.1056/nejm198109033051003openalex-snapshot
A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast Cancer
inferredcites →https://doi.org/10.1080/17843286.1963.11717155openalex-snapshot
Le Traitement Hormonal Du Cancer Du Sein En Phase Avancee. Méthodes détude : Comparaison de la Delta-1 -Testololactone avec le Propionate de Testostérone*
inferredcites →https://doi.org/10.1093/jnci/80.14.1147openalex-snapshot
Randomized Trial Comparing Aminoglutethimide With High-Dose Medroxyprogesterone Acetate in Therapy for Advanced Breast Carcinomau
inferredcites →https://doi.org/10.1097/00000421-198202000-00006openalex-snapshot
Dibromodulcitol and Adriamycin ± tamoxifen in advanced breast cancer*
inferredcites →https://doi.org/10.1097/00000421-198702000-00015openalex-snapshot
A Randomized Trial of Aminoglutethimide ± Estrogen Before Chemotherapy in Advanced Breast Cancer
inferredcites →https://doi.org/10.1097/00000421-198810000-00004openalex-snapshot
A Phase II Evaluation of Combination Chemotherapy Plus Aminoglutethimide in Women with Metastatic or Recurrent Breast Carcinoma An Eastern Cooperative Oncology Group Pilot Study
inferredcites →https://doi.org/10.1097/00000658-197805000-00004openalex-snapshot
Medical Adrenalectomy with Aminoglutethimide
inferredcites →https://doi.org/10.1111/j.1365-2265.1985.tb01083.xopenalex-snapshot
ENDOCRINE EFFECTS OF LOW DOSE AMINOGLUTETHIMIDE AS AN AROMATASE INHIBITOR IN THE TREATMENT OF BREAST CANCER
inferredcites →https://doi.org/10.1136/bmj.281.6250.1254openalex-snapshot
Systemic lupus erythematosus induced by aminoglutethimide.
inferredcites →https://doi.org/10.1136/bmj.283.6304.1432openalex-snapshot
Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.
inferredcites →https://doi.org/10.1159/000226639openalex-snapshot
Randomized Trial of Tamoxifen versus Aminoglutethimide and versus Combined Tamoxifen and Aminoglutethimide in Advanced Postmenopausal Breast Cancer
inferredcites →https://doi.org/10.1177/030089168507100512openalex-snapshot
Aminoglutethimide in Advanced Breast Cancer
inferredcites →https://doi.org/10.1200/jco.1986.4.6.958openalex-snapshot
Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer.
inferredcites →https://doi.org/10.1200/jco.1992.10.10.1547openalex-snapshot
Adjuvant aminoglutethimide for postmenopausal patients with primary breast cancer: analysis at 8 years.
inferredcites →https://doi.org/10.1200/jco.1992.10.3.438openalex-snapshot
Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and epidermal growth factor receptors and to tumor-node-metastasis staging.
inferredcites →https://doi.org/10.1200/jco.1992.10.6.984openalex-snapshot
Low-dose aminoglutethimide with and without hydrocortisone replacement as a first-line endocrine treatment in advanced breast cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
inferredcites →https://doi.org/10.1200/jco.1997.15.7.2494openalex-snapshot
Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial.
inferredcites →https://doi.org/10.1210/endo-105-1-52openalex-snapshot
Stereoselective Inhibition of Aromatase by Enantiomers of Aminoglutethimide*
inferredcites →https://doi.org/10.1210/endo-110-1-214openalex-snapshot
The Antiandrogenic Effects of Δ1-Testolactone (Teslac) in Vivo in Rats and in Vitro in Human Cultured Fibroblasts, Rat Mammary Carcinoma Cells, and Rat Prostate Cytosol*
inferredcites →https://doi.org/10.1210/jcem-27-4-473openalex-snapshot
Inhibition of Adrenal Corticosteroid Synthesis by Aminoglutethimide: Studies of the Mechanism of Action1
inferredcites →https://doi.org/10.1210/jcem-27-4-481openalex-snapshot
Effects of Amino-glutethimide on Adrenal Function in Man1
inferredcites →https://doi.org/10.1210/jcem-27-9-1239openalex-snapshot
Aminoglutethimide (Elipten-Ciba) as an Inhibitor of Adrenal Steroidogenesis: Mechanism of Action and Therapeutic Trial
inferredcites →https://doi.org/10.1210/jcem-36-2-207openalex-snapshot
Source of Estrogen Production in Postmenopausal Women1
inferredcites →https://doi.org/10.1210/jcem-45-4-739openalex-snapshot
Compensatory Increase in TSH Secretion without Effect on Prolactin Secretion in Patients Treated with Aminoglutethimide
inferredcites →https://doi.org/10.1210/jcem-47-4-717openalex-snapshot
Adrenal Suppression with Aminoglutethimide. III. Comparison of Plasma Δ 4 - and Δ 5 -Steroids in Postmenopausal Women Treated for Breast Carcinoma*
inferredcites →https://doi.org/10.1210/jcem-47-6-1257openalex-snapshot
Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*
inferredcites →https://doi.org/10.1210/jcem-49-5-672openalex-snapshot
Inhibition of Peripheral Aromatization of Androstenedione to Estrone in Postmenopausal Women with Breast Cancer Using Δ1Testololactone*
inferredcites →https://doi.org/10.1210/jcem-51-3-473openalex-snapshot
Resistance of the Ovary to Blockade of Aromatization with Aminoglutethimide*
inferredcites →https://doi.org/10.1210/jcem-55-4-718openalex-snapshot
Endocrine and Therapeutic Effects of Aminoglutethimide in Premenopausal Patients with Breast Cancer
inferredcites →https://doi.org/10.3109/02841869009092989openalex-snapshot
Second Line Hormonal Therapy with Aminoglutethimide in Metastatic Breast Cancer
inferredcites →https://doi.org/10.3109/07357908909038277openalex-snapshot
Low-Dose Aminoglutethimide Plus Steroid Replacement in Advanced Breast Cancer Patients Resistant to Conventional Therapies
inferredcites →https://doi.org/10.7326/0003-4819-100-1-160_1openalex-snapshot
Aminoglutethimide and Cholestasis
inferredcites →https://doi.org/10.7326/0003-4819-105-4-633_1openalex-snapshot
Aminoglutethimide, Alveolar Damage, and Hemorrhage
inferredcites →https://doi.org/10.7326/0003-4819-96-1-94openalex-snapshot
Aminoglutethimide as Treatment of Postmenopausal Women with Advanced Breast Carcinoma
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4172934openalex-extracted
Baeyer-Villiger Monooxygenases Using the FMO5 for the Detoxification of Testosterone and Dehydroepiandrosterone in LNCaP Cells
inferred← citeshttps://doi.org/10.1002/(sici)1097-0142(19960615)77:12<2503::aid-cncr13>3.0.co;2-wopenalex-snapshot
Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: Results of two randomized double blind controlled multiinstitutional trials
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm062openalex-snapshot
Endocrine Therapy for Hormone Receptor‐Positive Breast Cancer
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm062.pub2openalex-snapshot
Endocrine Therapy for Hormone Receptor‐Positive Breast Cancer
inferred← citeshttps://doi.org/10.1007/3-7643-7418-7_4openalex-snapshot
Clinical studies with exemestane
inferred← citeshttps://doi.org/10.1007/978-0-387-69805-2_24openalex-snapshot
Animal Models for Breast Cancer Prevention Research
inferred← citeshttps://doi.org/10.1007/978-1-4419-0507-9_17openalex-snapshot
New Molecular Therapeutic Interventions: The Case of Breast Cancers
inferred← citeshttps://doi.org/10.1007/978-1-59259-699-7_16openalex-snapshot
Aromatase Inhibitors in Breast Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-7643-8693-1_4openalex-snapshot
Clinical studies with exemestane
inferred← citeshttps://doi.org/10.1007/s00109-023-02300-zopenalex-snapshot
The crosstalk between ubiquitination and endocrine therapy
inferred← citeshttps://doi.org/10.1007/s10637-023-01332-zopenalex-snapshot
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells
inferred← citeshttps://doi.org/10.1007/s10870-016-0631-5openalex-snapshot
Synthesis, Structural Analysis and Cytotoxic Activity of Novel A- and B-Modified d-Homo Lactone Androstane Derivative
inferred← citeshttps://doi.org/10.1007/s11224-016-0815-9openalex-snapshot
Structural analysis and antitumor potential of novel 5,6-disubstituted-17a-homo-17-oxa-androstane derivatives
inferred← citeshttps://doi.org/10.1007/s12032-007-9019-xopenalex-snapshot
Aromatase inhibitors: past, present and future in breast cancer therapy
inferred← citeshttps://doi.org/10.1016/b978-0-12-398339-8.00003-3openalex-snapshot
Animal Models of Idiosyncratic Drug Reactions
inferred← citeshttps://doi.org/10.1016/j.bcab.2020.101546openalex-snapshot
Cascate reactions of progesterone by mycelia and culture broth from marine-derived fungus Aspergillus sydowii CBMAI 935
inferred← citeshttps://doi.org/10.1016/j.bioorg.2021.105017openalex-snapshot
A review on diverse heterocyclic compounds as the privileged scaffolds in non-steroidal aromatase inhibitors
inferred← citeshttps://doi.org/10.1016/j.brainres.2007.06.047openalex-snapshot
Nanomolar concentrations of anabolic–androgenic steroids amplify excitotoxic neuronal death in mixed mouse cortical cultures
inferred← citeshttps://doi.org/10.1016/j.cbi.2004.09.001openalex-snapshot
Animal models of idiosyncratic drug reactions
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2022.112597openalex-snapshot
Hormone receptor binding, selectivity and cytotoxicity of steroid D-homo lactone loaded chitosan nanoparticles for the treatment of breast and prostate cancer cells
inferred← citeshttps://doi.org/10.1016/j.farmac.2005.01.011openalex-snapshot
Synthesis and study of some new N-substituted imide derivatives as potential anticancer agents
inferred← citeshttps://doi.org/10.1016/j.jaci.2013.05.027openalex-snapshot
The steroidogenic enzyme Cyp11a1 is essential for development of peanut-induced intestinal anaphylaxis
inferred← citeshttps://doi.org/10.1016/j.mcpsp.2022.100356openalex-snapshot
Aromatase inhibitors in male: A literature review
inferred← citeshttps://doi.org/10.1016/j.molstruc.2015.12.030openalex-snapshot
Computational and anti-tumor studies of 7a-Aza-B-homostigmast-5-eno [7a, 7-d] tetrazole-3β-yl chloride
inferred← citeshttps://doi.org/10.1016/j.steroids.2007.09.005openalex-snapshot
Synthesis of some epoxy and/or N-oxy 17-picolyl and 17-picolinylidene-androst-5-ene derivatives and evaluation of their biological activity
inferred← citeshttps://doi.org/10.1016/j.steroids.2020.108596openalex-snapshot
New A-homo lactam D-homo lactone androstane derivative: Synthesis and evaluation of cytotoxic and anti-inflammatory activities in vitro
inferred← citeshttps://doi.org/10.1016/j.steroids.2024.109392openalex-snapshot
Bio-oxidation of progesterone by Penicillium oxalicum CBMAI 1185 and evaluation of the cytotoxic activity
inferred← citeshttps://doi.org/10.1016/j.tet.2013.11.039openalex-snapshot
Biotransformations of steroids to testololactone by a multifunctional strain Penicillium simplicissimum WY134-2
inferred← citeshttps://doi.org/10.1016/s0014-827x(99)00018-xopenalex-snapshot
New heterocyclic derivatives of benzimidazole with germicidal activity
inferred← citeshttps://doi.org/10.1016/s0040-4020(97)10436-7openalex-snapshot
The synthesis of (±)-aminoglutethimide via vicarious nucleophilic aromatic substitution of hydrogen
inferred← citeshttps://doi.org/10.1016/s0305-0491(99)00053-xopenalex-snapshot
Steroidogenesis in the fungus Pleurotus ostreatus
inferred← citeshttps://doi.org/10.1016/s0305-7372(97)90037-2openalex-snapshot
Aromatase inhibitors and breast cancer
inferred← citeshttps://doi.org/10.1016/s0305-7372(98)90051-2openalex-snapshot
Hormonal therapy of breast cancer
inferred← citeshttps://doi.org/10.1016/s1055-3207(18)30428-9openalex-snapshot
Hormonal Treatment of Advanced Breast Cancer
inferred← citeshttps://doi.org/10.1021/jm801514wopenalex-snapshot
Novel Chemical Space Exploration via Natural Products
inferred← citeshttps://doi.org/10.1021/tx400224jopenalex-snapshot
Effect of Aminoglutethimide on Neutrophils in Rats: Implications for Idiosyncratic Drug-Induced Blood Dyscrasias
inferred← citeshttps://doi.org/10.1039/c2md20327hopenalex-snapshot
Selective antitumour activity and ERα molecular docking studies of newly synthesized d -homo fused steroidal tetrazoles
inferred← citeshttps://doi.org/10.1039/c3ra41336eopenalex-snapshot
Synthesis, structural analysis and antiproliferative activity of some novel D-homo lactone androstane derivatives
inferred← citeshttps://doi.org/10.1046/j.1471-4159.2004.02284.xopenalex-snapshot
Testosterone amplifies excitotoxic damage of cultured oligodendrocytes
inferred← citeshttps://doi.org/10.1081/jlc-100101829openalex-snapshot
ENANTIOMERIC SEPARATION OF AMINOGLUTETHIMIDE, ACETYL AMINOGLUTETHIMIDE, AND DANSYL AMINOGLUTETHIMIDE BY TLC WITH β-CYCLODEXTRIN AND DERIVATIVES AS MOBILE PHASE ADDITIVES
inferred← citeshttps://doi.org/10.1093/oxfordjournals.annonc.a010490openalex-snapshot
Letrozole, a new oral non-steroidal aromastase inhibitor in treating postmenopausal patients with advanced breast cancer. A pilot study
inferred← citeshttps://doi.org/10.1093/oxfordjournals.annonc.a010629openalex-snapshot
New generation of aromatase inhibitros: Prospects of a major advantage for the patients
inferred← citeshttps://doi.org/10.1097/00045391-200109000-00007openalex-snapshot
Aromatase, Aromatase Inhibitors, and Breast Cancer
inferred← citeshttps://doi.org/10.1158/0008-5472.can-06-2134openalex-snapshot
Aromatase Destabilizer: Novel Action of Exemestane, a Food and Drug Administration–Approved Aromatase Inhibitor
inferred← citeshttps://doi.org/10.1186/s43094-025-00914-3openalex-snapshot
Synthesis, characterization, biological screening and in silico studies of novel pyrazole-chalcone derivatives as potent aromatase inhibitors for breast cancer therapy
inferred← citeshttps://doi.org/10.1210/en.142.4.1497openalex-snapshot
Constitutive Expression of the Steroid Sulfatase Gene Supports the Growth of MCF-7 Human Breast Cancer Cells in Vitro and in Vivo
inferred← citeshttps://doi.org/10.1210/er.2004-0015openalex-snapshot
Aromatase Inhibitors in the Treatment of Breast Cancer
inferred← citeshttps://doi.org/10.1210/er.2008-0016openalex-snapshot
History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target
inferred← citeshttps://doi.org/10.1210/jcem.83.3.4623openalex-snapshot
Testolactone-Associated High Androgen Levels, a Pharmacologic Effect or a Laboratory Artifact?1
inferred← citeshttps://doi.org/10.1507/endocrj.ej16-0022openalex-snapshot
How far have we come in terms of estrogens in breast cancer? [Review]
inferred← citeshttps://doi.org/10.1517/14656566.7.14.1919openalex-snapshot
Update on the use of aromatase inhibitors in breast cancer
inferred← citeshttps://doi.org/10.1530/erc-17-0416openalex-snapshot
A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers
inferred← citeshttps://doi.org/10.1586/14737140.2.2.181openalex-snapshot
Aromatase inhibitors in breast cancer therapy
inferred← citeshttps://doi.org/10.1586/14750708.1.2.305openalex-snapshot
Adjuvant endocrine therapy for postmenopausal women with early stage breast cancer
inferred← citeshttps://doi.org/10.1677/erc.0.0060075openalex-snapshot
Use of aromatase inhibitors in breast carcinoma.
inferred← citeshttps://doi.org/10.2165/00019053-200017020-00002openalex-snapshot
New Generation Aromatase Inhibitors in Breast Cancer
inferred← citeshttps://doi.org/10.2174/1389200221666200520092333openalex-snapshot
Tumor-targeted Drug Delivery by Nanocomposites
inferred← citeshttps://doi.org/10.2174/187152008785133092openalex-snapshot
Natural Products as Aromatase Inhibitors
inferred← citeshttps://doi.org/10.2174/1871520620666200627204105openalex-snapshot
Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch
inferred← citeshttps://doi.org/10.22028/d291-22616openalex-snapshot
Natural and synthetic flavonoid derivatives with potential antioxidant and anticancer activities
inferred← citeshttps://doi.org/10.3109/1547691x.2013.867912openalex-snapshot
Hepatic effects of aminoglutethimide: A model aromatic amine
inferred← citeshttps://doi.org/10.3390/ddc2010005openalex-snapshot
Testolactone: The Rise and Fall of a Drug
inferred← citeshttps://doi.org/10.3390/nutraceuticals5040037openalex-snapshot
A Narrative Review on Breast Cancer Treatment Supported by Focused and Systemic Phytotherapy
inferred← citeshttps://doi.org/10.4018/978-1-4666-8136-1.ch011openalex-snapshot
Ligand- and Structure-Based Drug Design of Non-Steroidal Aromatase Inhibitors (NSAIs) in Breast Cancer
inferred← citeshttps://doi.org/10.4018/978-1-5225-0549-5.ch004openalex-snapshot
Ligand- and Structure-Based Drug Design of Non-Steroidal Aromatase Inhibitors (NSAIs) in Breast Cancer
inferred← citeshttps://doi.org/10.4172/2161-0444.1000252openalex-snapshot
Drug Targets for Cancer Treatment: An Overview
inferred← citeshttps://doi.org/10.5530/ijper.56.2.51openalex-snapshot
Aromatase Inhibitors: Development and Current Perspectives
inferred← citeshttps://doi.org/10.7939/r39s1kw71openalex-snapshot
An investigation of aminoglutethimide cytotoxicity and its role in activation of cell death signaling pathways
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.